NCT02295059 2025-09-16
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
City of Hope Medical Center
Phase NA Active not recruiting
Clinical Trials
7 trialsNCT02831582 2023-02-27
Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT01821833 2022-10-05
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
New Mexico Cancer Research Alliance
Phase NA Completed
NCT02101970 2022-01-24
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
University of Kansas Medical Center
Phase NA Completed
NCT02352779 2017-08-08
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
University of Rochester
Phase NA Completed
NCT00627276 2017-04-27
Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia
OHSU Knight Cancer Institute
Phase NA Completed
NCT00114296 2013-09-17
Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown